VJHemOnc is committed to improving our service to you

COMy 2019 | Predicting MM response to cellular and immunotherapies

VJHemOnc is committed to improving our service to you

Paola Neri

Paola Neri, MD, PhD, University of Calgary, Calgary, AB, Canada, discusses how immune deregulation can be used to predict response to cellular therapies and immunotherapies, such as CAR T-cell products and monocloncal antibodies. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter